A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas.
about
Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disordersm-TOR inhibitors and their potential role in haematological malignancies.Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma.Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma.Recent advances in understanding and managing T-cell lymphoma.Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients.Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.
P2860
Q37437248-1D74E3C2-08B7-4124-A911-D6EA14697DD7Q39113506-A5671779-6465-4473-9FCD-02B1921F10B1Q42322772-30B684FC-B309-427A-9E46-5D6DDF98A027Q47097471-C8F472A6-D157-4358-B15E-54212C64DBA7Q47131247-4957E442-884F-49B3-9E58-232AA74BA9C0Q47320024-FC498981-6893-4957-A5C7-6A2E609477EAQ48185230-0B93C7A0-9C44-4B90-B6DC-B8C465874B86Q49240447-70EADA1A-C29B-4F04-B58A-B6DD18FD1CFD
P2860
A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A phase II study of everolimus ...... d peripheral T-cell lymphomas.
@ast
A phase II study of everolimus ...... d peripheral T-cell lymphomas.
@en
type
label
A phase II study of everolimus ...... d peripheral T-cell lymphomas.
@ast
A phase II study of everolimus ...... d peripheral T-cell lymphomas.
@en
prefLabel
A phase II study of everolimus ...... d peripheral T-cell lymphomas.
@ast
A phase II study of everolimus ...... d peripheral T-cell lymphomas.
@en
P2093
P2860
P356
P1433
P1476
A phase II study of everolimus ...... d peripheral T-cell lymphomas.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDV624
P577
2016-02-08T00:00:00Z